- Home
- IPHA vs BHST Comparison
IPHA vs BHST Comparison
Compare IPHA & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- BHST
- Stock Information
- Founded
- IPHA 1999
- BHST 2007
- Country
- IPHA France
- BHST Canada
- Employees
- IPHA N/A
- BHST N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- BHST
- Sector
- IPHA Health Care
- BHST
- Exchange
- IPHA Nasdaq
- BHST Nasdaq
- Market Cap
- IPHA 160.1M
- BHST 128.4M
- IPO Year
- IPHA 2019
- BHST N/A
- Fundamental
- Price
- IPHA $2.11
- BHST $7.67
- Analyst Decision
- IPHA Strong Buy
- BHST Strong Buy
- Analyst Count
- IPHA 1
- BHST 2
- Target Price
- IPHA $11.00
- BHST $13.00
- AVG Volume (30 Days)
- IPHA 13.4K
- BHST 9.4K
- Earning Date
- IPHA 09-11-2025
- BHST 08-11-2025
- Dividend Yield
- IPHA N/A
- BHST N/A
- EPS Growth
- IPHA N/A
- BHST N/A
- EPS
- IPHA N/A
- BHST N/A
- Revenue
- IPHA $20,831,349.00
- BHST $27,704,000.00
- Revenue This Year
- IPHA $278.51
- BHST $116.40
- Revenue Next Year
- IPHA $70.16
- BHST $55.91
- P/E Ratio
- IPHA N/A
- BHST N/A
- Revenue Growth
- IPHA N/A
- BHST 74.76
- 52 Week Low
- IPHA $1.29
- BHST $4.66
- 52 Week High
- IPHA $3.51
- BHST $7.99
- Technical
- Relative Strength Index (RSI)
- IPHA 60.15
- BHST N/A
- Support Level
- IPHA $1.71
- BHST N/A
- Resistance Level
- IPHA $2.63
- BHST N/A
- Average True Range (ATR)
- IPHA 0.14
- BHST 0.00
- MACD
- IPHA 0.03
- BHST 0.00
- Stochastic Oscillator
- IPHA 41.83
- BHST 0.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.